Company Filing History:
2 out of 2 
2 out of 2 
2 out of 282 
Years Active: 2024-2025
Title: Timo Wittenberger: Innovator in Cancer Detection
Introduction
Timo Wittenberger is a notable inventor based in Constance, Germany. He has made significant contributions to the field of cancer detection through his innovative research and patented technologies. With a focus on epigenetic markers, his work aims to improve the diagnosis and management of certain cancers.
Latest Patents
Timo Wittenberger holds 2 patents related to epigenetic markers and methods for detecting and managing cancers. His latest patent involves methods for determining the presence or absence of certain cancers in individuals, particularly ovarian cancer in women. This invention utilizes the detection of methylated or unmethylated CpGs associated with differentially methylated regions (DMRs) in cell-free DNA. The methods developed have diagnostic, prognostic, and predictive utility for managing cancers, providing valuable insights into therapy responses.
Career Highlights
Throughout his career, Timo has worked with prominent companies in the genomics and biotechnology sectors. He has been associated with Eurofins Genomics Europe Sequencing GmbH and Genedata AG, where he has contributed to advancements in genomic sequencing and data analysis.
Collaborations
Timo Wittenberger has collaborated with esteemed colleagues, including Martin Widschwendter and Allison Jones. These partnerships have further enhanced his research and innovation in the field of cancer detection.
Conclusion
Timo Wittenberger's work in developing methods for cancer detection through epigenetic markers represents a significant advancement in medical technology. His contributions are poised to improve the lives of many individuals facing cancer diagnoses.